Last updated 2026-07-27
- Went public on NASDAQ (AIFF), Feb 2011
- Raised $28M Series B led by OurCrowd, Oct 2015
- Raised $6.4M Series C led by OurCrowd, May 2018
Total raised
$60.9M
Last: Public Offering 2026-04
Stage
Public
Founded
2006
Headcount
23
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Firefly Neuroscience is a medical technology company focused on objective brain health assessment through its FDA-cleared Brain Network Analytics (BNA™) platform. The company develops AI and advanced signal processing technology that records and compares brain function to an FDA-cleared, age-matched database of over 200,000 EEG and ERP recordings. This technology enables clinicians and patients to make informed therapy and disease management decisions and track changes over time for conditions such as concussion, cognitive decline, depression, anxiety, ADHD, PTSD, and other brain-based disorders.
Funding history · 20 rounds · $60.9M total
2026-07
Follow-on PO
Undisclosed
2026-05
PIPE
Undisclosed
2026-02
Follow-on PO
Undisclosed
2025-12
PIPE
Undisclosed
2025-08
Follow-on PO
Undisclosed
2025-04
PIPE
Undisclosed
2024-12
Debt Financing
Undisclosed
2024-08
PIPE
Undisclosed
2024-02
Follow-on PO
Undisclosed
2022-08
Follow-on PO
Undisclosed
2022-07
PIPE
Undisclosed
2021-12
PIPE
Undisclosed
2021-04
IPO
Undisclosed
2020-05
E Round
$3.5M
★ OurCrowd
2019-03
D Round
$2.3M
★ OurCrowd
2019-02
Grant
$3.3M
2018-05
C Round
$6.4M
★ OurCrowd
2015-10
B Round
$28.0M
★ OurCrowd★ WR Hambrecht★ Shanda Group★ Wexford Capital★ Palisade Capital Management
2011-11
A Round
$13.8M
2006-05
Seed
$3.6M
Headcount over time
From 52 (2018-08) to 24 (2026-03) · -28 (-54%) · 41 points · source: Finder history + radar grounding
Q&A
- What is Firefly Neuroscience's primary business?
- Firefly Neuroscience is a medical technology company that focuses on objective brain health assessment using its FDA-cleared Brain Network Analytics (BNA™) platform. They develop AI and advanced signal processing technology to record and compare brain function to a large, age-matched database.
- When did Firefly Neuroscience go public?
- Firefly Neuroscience went public on NASDAQ in November 2021.
- What was Firefly Neuroscience's most recent funding event?
- Firefly Neuroscience completed a PIPE funding round in May 2026, raising $1,000,000.
- What was Firefly Neuroscience's most recent acquisition?
- In May 2025, Firefly Neuroscience acquired Evoke Neuroscience for $6,000,000.
- What is the current employee count for Firefly Neuroscience?
- Firefly Neuroscience currently has 11-50 employees.
- What is a recent strategic partnership for Firefly Neuroscience?
- In September 2024, Firefly Neuroscience announced a partnership with Zeto to integrate and distribute its BNA™ Technology with Zeto's FDA-cleared EEG device platform.
- What is Firefly Neuroscience's total funding raised to date?
- Firefly Neuroscience has raised a total of $82,590,000 USD.
- What is a recent development regarding Firefly Neuroscience's technology?
- In March 2026, Firefly Neuroscience progressed toward the development and commercial launch of its Foundation Model of the Human Brain, powered by NVIDIA GPU Acceleration.
- Has Firefly Neuroscience recently expanded its commercial footprint?
- In May 2025, Firefly Neuroscience achieved multi-fold database, IP portfolio, and commercial footprint expansion through the acquisition of Evoke Neuroscience, Inc.
- What is Firefly Neuroscience's market capitalization?
- Firefly Neuroscience has a market capitalization of $11,806,312 USD.
Team · 7
Amir Geva
Founder · Founder & CTO
executives
executives
executives
executives
Chen Golan
executives
executives
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
machine-learningpersonalizationbrain-disorderalzheimers-diseasedecision-supportmappingmental-healthpsychiatrydigital-healthcareneurologypharma-companiesmedical-devicesclinical-trialsimaginghealthcare-providersdegenerative-diseasesartificial-intelligencenon-invasivemedical-cannabisdiagnosticsparkinsonmedical-technologiesdeep-learningdoctorssaas
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fireflyneuro.com/ |
|---|---|
| linkedin.com/company/2531441 | |
| Crunchbase | crunchbase.com/organization/elminda |
Identifiers & details
| Former names | elminda |
|---|---|
| Founded | 2006-1 |
| Employees (exact) | 23 |
| Offices | Oakville; Buffalo |
| Market cap | $11.8M |
| Status reason | Public on NASDAQ on Nov, 2021; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| 2025-05 | $6.0M |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2011-02 | NASDAQ | AIFF |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513851162 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2006-07-04 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | משכית 14 הרצליה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-06 | עדכון חיובים במג~ק |